Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 453 publications.

Gonzalez-Roca E, Garcia-Albeniz X, Rodriguez-Mulero S, Gomis RR, Kornacker K, Auer H. Accurate expression profiling of very small cell populations. PLoS One. 2010 Dec 28;5(12):e14418. doi: 10.1371/journal.pone.0014418

Mauskopf J, Annemans L, Hill AM, Smets E. A review of economic evaluations of darunavir boosted by low-dose ritonavir in treatment-experienced persons living with HIV infection. Pharmacoeconomics. 2010 Dec 23;28(Suppl 1):1-16.

Smets E, Brogan AJ, Mauskopf J, Talbird SE. US cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, HIV-infected adults with evidence of protease inhibitor resistance included in the TITAN Trial. Pharmacoeconomics. 2010 Dec 23;28(Suppl 1):129-46.

Colin X, Lafuma A, Costagliola D, Smets E, Mauskopf J, Guillon P. Modelling the budget impact of darunavir in the treatment of highly treatment-experienced, HIV-infected adults in France. Pharmacoeconomics. 2010 Dec 23;28(Suppl 1):183-97.

Khilko N, Wang J, Wei B, Hicks DG, Tang P. Invasive lobular carcinomas do not express basal cytokeratin markers CK5/6, CK14 and CK17. Breast Cancer (Auckl). 2010 Dec 2;2010(4):49-55.

Fehnel SE, Manjunath R, Ervin CM, French JA, Vanlandingham K, Sweeney CT. Developing a functional status diary for epilepsy. Poster presented at the 64th Annual Meeting of the American Epilepsy Society; December 1, 2010.

McKenna SP, Doward LC, Twiss J, Hagell P, Oprandi NC, Fisk J, Grand'Maison F, Bhan V, Arbizu T, Brassat D, Kohlmann T, Meads DM, Eckert BJ. International development of the Patient-Reported Outcome Indices for Multiple Sclerosis (PRIMUS). Value Health. 2010 Dec 1;13(8):946-51.

Dalal AA, Demuro-Mercon C, Lewis S, Nelson L, Gilligan T, McLeod L. Validation of alternate modes of administration of the lung function questionnaire (LFQ) in subjects with smoking history. Int J Chron Obstruct Pulmon Dis. 2010 Dec 1;5:425-34.

Chung RT, Poordad FF, Hassanein T, Zhou X, Lentz E, Prabhakar A, Di Bisceglie AM. Association of host pharmacodynamic effects with virologic response to pegylated interferon alfa-2a/ribavirin in chronic hepatitis C. Hepatology. 2010 Dec 1;52(6):1906-14. doi: 10.1002/hep.23947

Mohamed AF, Hauber AB, Johnson FR, Coon CD. Patient preferences and linear scoring rules for patient-reported outcomes. Patient. 2010 Dec 1;3(4):217-27.

Wang J, Sherrill B, Hamm LA, Mangel AW. Does timing of colon procedures affect outcomes in D-IBS trials? Gastroenterology Research. 2010 Dec 1;3(5):185-90.

Earnshaw SR, Taylor TN, McDade CL. Pharmacoeconomics and the drug development process.. In: Yih Y, editors. Handbook of healthcare delivery systems. Boca Raton: FL. CRC Press; 2010.

Meyers J, Classi P, Wietecha L, Candrilli S. Economic burden and comorbidities of attention-deficit/hyperactivity disorder among pediatric patients hospitalized in the United States. Child Adolesc Psychiatry Ment Health. 2010 Dec 1;4:31.

Konstan MW, Rasouliyan L, Pasta DJ, Yegin A, Morgan WJ, Wagener JS, Scientific Advisory, Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Trends in the use of routine therapies in cystic fibrosis: 1995-2005. Pediatr Pulmonol. 2010 Dec;45(12):1167-72. doi: 10.1002/ppul.21315

Hoffman E. Applications of path analysis & structural equation models in environmental health studies. Presented at the Program in Quantitative Genomics, Harvard School of Public Health; December 2010. Boston, MA.

Stevenson AL, Juanes PP, McCarthy JE. Elucidating mechanistic principles underpinning eukaryotic translation initiation using quantitative fluorescence methods. Biochem Soc Trans. 2010 Dec;38(6):1587-92. doi: 10.1042/BST0381587

Marshall D, Bridges JFP, Hauber B, Cameron R, Donnalley L, Fyie K, Johnson FR. Conjoint analysis applications in health - How are studies being designed and reported?: an update on current practice in the published literature between 2005 and 2008. Patient. 2010 Dec 1;3(4):249-56.

Vinceti M, Bonvicini F, Rothman KJ, Vescovi L, Wang FY. The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a population-based case-control study. Environ Health. 2010 Dec 1;9(Art. No. 77).

Roskell NS, Lip GY, Noack H, Clemens A, Plumb JM. Treatments for stroke prevention in atrial fibrillation: a network meta-analysis and indirect comparisons versus dabigatran etexilate. Thromb Haemost. 2010 Dec 1;104(6):1106-15.

Lang K, Meyers JL, Korn JR, Lee S, Sikirica M, Crivera C, Dirani R, Menzin J. Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics. Psychiatr Serv. 2010 Dec 1;61(12):1239-47.

Leidy NK, Wilcox TK, Jones PW, Murray L, Winnette RM, Howard K, Petrillo J, Powers J, Sethi S. Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome (PRO) measure. Value Health. 2010 Dec;13(8):965-75. doi: 10.1111/j.1524-4733.2010.00772.x

Roussy JP, Kwan H, Earnshaw SR, Farkouh RA, Hwang S, Strutton D. Cost-effectiveness of 13-valent pneumococcal conjugate vaccine compared with 10-valent vaccine in preventing pneumococcal infections in Quebec. Poster presented at the 9th Canadian Immunization Conference; December 2010. Previously presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy.

Ribeiro-Oliveira Jr A, Mol SS, Twiss J, Alencar GA, Miranda PA, Naves LA, Azevedo MF, Basilio FM, Boguszewski CL, Nogueira KC, Vilar L, Koltowska-Haggstrom M, McKenna SP. The brazilian version of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA): four-stage translation and validation. Arq Bras Endocrinol Metabol. 2010 Dec;54(9):833-41.

Launois R, Le Moine JG, Huynh MT, Boissier MC. Efficacité et tolérance des traitements de la polyarthrite rhumatoïde étudiés par méta-analyse hiérarchique bayésienne: combinaison simultanée des résultats relevés dans les essais randomisés et les études observationnelles avec groupe controle. Presented at the French Society of Rheumatology 23rd Annual Congress; November 28, 2010. Paris, France.

Talbird SE, Taylor TN, Caporale J, Ismaila AS, Gomez J. Residual economic burden of Streptococcus pneumoniae- and nontypeable Haemophilus influenzae- associated disease following vaccination with PCV-7: a multicountry analysis. Vaccine. 2010 Nov 19;28(Suppl 6):G14-22.

Talbird SE, Taylor TN, Knoll S, Frostad CR, Marti SG. Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries. Vaccine. 2010 Nov 19;28(Suppl 6):G23-9.

Talbird SE, Ismaila AS, Taylor TN. A steady-state, population-based model to estimate the direct and indirect effects of pneumococcal vaccines. Vaccine. 2010 Nov 19;28(Suppl 6):G3-G13.

Stafkey-Mailey DR, Bennett CL, Dickson M. Racial/ethnic disparities of erythropoiesis stimulating agent use among the insured poor: pre- and post-safety advisories. Presented at the 52nd American Society of Hematology (ASH) Annual Meeting and Exposition; December 2010. Orlando, FL. [abstract] Blood. 2010 Nov 19; 116(21):395. doi: 10.1182/blood.V116.21.395.395

Standaert B, Demarteau N, Talbird S, Mauskopf J. Modelling the effect of conjugate vaccines in pneumococcal disease: cohort or population models? Vaccine. 2010 Nov 19;28(Suppl 6):G30-8.

Williams VSL, Carson RT, Nelson LM, MacDougall J, Fehnel SE, Lewis B, Johnston JM. Application of exploratory factor analysis to support the conceptual framework of PRO measures: results from a phase 2 study of irritable bowel syndrome with constipation. Poster presented at the International Society for Quality of Life Research (ISOQOL) 2010 Annual Meeting; November 18, 2010.

Norquist JM, Girman CJ, Fehnel S, DeMuro C, Santanello N. Choice of recall period for patient-reported outcome measures: criteria for consideration. Poster presented at the International Society for Quality of Life Research (ISOQOL) 2010 Annual Meeting; November 18, 2010.

Rycroft CE, Leeuwenkamp O, Heikkinen T, Principi N, Herz J, Moren A, Beard SM. Economic and Clinical Burden of Paediatric Influenza in Nine European Countries. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010.

Beard SM, Le TK, Zhao Y, Roskell N. The Cost-effectiveness of Duloxetine in the Treatment of Fibromyalgia in the United States. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010.

Harris DH. Six degrees of separation no more: using data linkages to improve the quality of cancer registry and study data. Poster presented at the American Public Health Association Annual Meeting & Exposition; November 6, 2010. Denver, CO.

Arana A, Ayuso-Mateos JL, Arellano FM. Suicide-related events in patients treated with antiepileptic drugs. Authors reply. N Engl J Med. 2010 Nov 4;363(19):1873-4.

Evans ED, Mangel AW. Depolarization-stimulated contractility of gastrointestinal smooth muscle in calcium-free solution: a review. Isrn Gastroenterol. 2010 Nov 3;2011(2011):692528. doi: 10.5402/2011/692528

Valdivieso E, Rey C, Barrera M, Arija V, Basora J, Marsal JR, TAB_ES Study Group. Factors associated with commencing smoking in 12-year-old students in Catalonia (Spain): a cross-sectional population-based study. BMC Public Health. 2010 Nov 2;10:665. doi: 10.1186/1471-2458-10-665

Johnson FR, Mohamed AF, Hauber AB, Lescrauwaet B. Is it possible to obtain willingness-to-pay estimates in Europe? A validity test of stated preferences for hepatitis b treatments. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. [abstract] Value Health. 2010 Nov; 13(7):A445.

Johnson FR, Gonzalez JM, Hauber AB. Patients' stated health outcome preferences for confounded patient-reported outcome domains for osteoarthritis. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. [abstract] Value Health. 2010 Nov; 13(7):A312.

Bunniran S, Banahan III BF, Bentley JP, Torres LR, West DS, Ross LA. Patient reported behaviors in coping with Medicaid prescription caps. Poster presented at the 2010 American Public Health Association Annual Meeting; November 2010. Denver, CO.

Abu-Assi E, Ferreira-Gonzalez I, Ribera A, Marsal JR, Cascant P, Heras M, Bueno H, Sanchez PL, Aros F, Marrugat J, Garcia-Dorado D, Pena-Gil C, Gonzalez-Juanatey JR, Permanyer-Miralda G. Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes? Am Heart J. 2010 Nov;160(5):826-34. doi: 10.1016/j.ahj.2010.06.053

Goldberg M, Li Y-P, Johanson JF, Mangel AW, Kitt M, Beattie DT, Kersey K, Daniels O. Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation – a 4-week, randomized, double-blind, placebo-controlled, dose–response study. Aliment Pharmacol Ther. 2010 Nov 1;32(9):1102-12.

Mohamed AF, Hauber B, Masterson A, Lescrauwaet B. Patient preferences for benefits, risks, and weight of evidence associated with hepatitis b treatments. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. [abstract] Value Health. 2010 Nov; 13(7):A441.

O'Neil P, Hawe E, Baillie L. Shedding the Pounds: obesity management, NICE guidance and bariatric surgery in England. November 2010 ed. London: United Kingdom. OHE Consulting report; 2010.

Davis KL, Iyer S, Candrilli S. Predictors of the direct costs of breast cancer in the United States elderly population. the 2010 ISPOR 13th Annual European Congress; Madrid, Spain. [abstract] Value Health. 2010 Nov 1; 13(7):A260.

Twiss J, McKenna S, Doward LC, Hana V, Karbownik-Lewinksa M, Popovic V. Further developments of the Quality of Life Assessment of Growth Hormone Deficiency in Adults (QOL-AGHDA). Poster presented at the 13th Annual European Congress; November 2010. Prague, Czech Republic. [abstract] Value Health. 2010 Nov; 13(7):A297.

Twiss J, McKenna S, Crawford SR, Doward LC. Scaling properties of two commonly used outcome measures in dermatology – the Dermatology Life Quality Index (DLQI) and the Psoriasis Quality of Life Scale (PSORIQoL). Presented at the 13th Annual European Congress; November 2010. Prague, Czech Republic. [abstract] Value Health. 2010 Nov; 13(7):A244.

Candrilli SD, O'Brien SH, Balkrishnan R. Economic outcomes associated with hydroxyurea adherence among pediatric Medicaid enrollees with sickle cell disease. Poster presented at the 2010 ISPOR 13th Annual European Congress; November 15, 2010. [abstract] Value Health. 2010 Nov; 13(7):A463.

DeMuro-Mercon CJ, DiBenedetti DB, Lewis SA, Fehnel SE. Successful implementation of the cognitive interviews in special populations. Presented at the 17th Annual Conference of the International Society for Quality of Life Research; November 1, 2010. Previously presented at the 16th Annual Conference of the International Society for Quality of Life Research.

Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH. The prevalence of chronic pain in United States adults: results of an internet-based survey. J Pain. 2010 Nov 1;11(11):1230-9.